SETD2 and renal carcinoma: Based on an analysis of 79 genes associated with renal cancer, we found that VHL, PBRM1, BAP1, SETD2, and TSC1 mutation rates were higher in all RCCs at 51%, 35%, 16%, 15%, and 13%, respectively (Figure 2).